Home
ALNY
ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on February 23, 2025

MT Newswires

4 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $787,904, According to a Recent SEC Filing

MT Newswires

4 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $531,448, According to a Recent SEC Filing

MT Newswires

4 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $309,527, According to a Recent SEC Filing

SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag

Zacks

5 days ago

SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag

Morningstar Research

8 days ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y

Zacks

9 days ago

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y

MT Newswires

9 days ago

RBC Raises Price Target on Alnylam Pharmaceuticals to $310 From $300, Keeps Outperform Rating

Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

9 days ago

Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

9 days ago

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Thomson Reuters StreetEvents

9 days ago

Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call

Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

10 days ago

Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates

Zacks

10 days ago

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates

MT Newswires

10 days ago

Alnylam Pharmaceuticals Swings to Q4 Earnings, Revenue Rises

Associated Press Finance

10 days ago

Alnylam: Q4 Earnings Snapshot

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

Business Wire

10 days ago

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints

Zacks

10 days ago

Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints

ILMN vs. ALNY: Which Stock Is the Better Value Option?

Zacks

11 days ago

ILMN vs. ALNY: Which Stock Is the Better Value Option?

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?

Zacks

12 days ago

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

13 days ago

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks

16 days ago

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

17 days ago

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Are Medical Stocks Lagging Guardant Health (GH) This Year?

Zacks

17 days ago

Are Medical Stocks Lagging Guardant Health (GH) This Year?

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales

Zacks

18 days ago

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

Zacks

19 days ago

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

Bet on These 4 Top-Performing Liquid Stocks for Solid Gains

Zacks

20 days ago

Bet on These 4 Top-Performing Liquid Stocks for Solid Gains

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results

Business Wire

24 days ago

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

24 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $14,988,720, According to a Recent SEC Filing

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Zacks

25 days ago

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

New Strong Buy Stocks for January 27th

Zacks

a month ago

New Strong Buy Stocks for January 27th

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

a month ago

Exploring Three High Growth Tech Stocks In The United States

GILD vs. ALNY: Which Stock Is the Better Value Option?

Zacks

a month ago

GILD vs. ALNY: Which Stock Is the Better Value Option?

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock

Zacks

a month ago

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock

Morningstar Research

a month ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Best Momentum Stocks to Buy for January 21st

Zacks

a month ago

Best Momentum Stocks to Buy for January 21st

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Zacks

a month ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

New Strong Buy Stocks for January 21st

Zacks

a month ago

New Strong Buy Stocks for January 21st

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals

Zacks

a month ago

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Business Wire

a month ago

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Business Wire

2 months ago

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Exploring High Growth Tech Stocks in the US December 2024

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks in the US December 2024

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?

Insider Monkey

2 months ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam

Zacks

2 months ago

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

Zacks

2 months ago

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $439,760, According to a Recent SEC Filing

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study

Zacks

2 months ago

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study

What Makes Alnylam (ALNY) a New Buy Stock

Zacks

3 months ago

What Makes Alnylam (ALNY) a New Buy Stock

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Zacks

3 months ago

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insider Monkey

3 months ago

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?

MT Newswires

3 months ago

Mirae Asset Downgrades Alnylam Pharmaceuticals to Hold, Price Target is $236

MT Newswires

3 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing

MT Newswires

3 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference

Business Wire

3 months ago

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

BioPharma Dive

3 months ago

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

Zacks

3 months ago

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug

Investor's Business Daily

3 months ago

BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The United States

MT Newswires

3 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires

3 months ago

Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Business Wire

3 months ago

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

BridgeBio heart drug approved by FDA, setting up battle with Pfizer

BioPharma Dive

3 months ago

BridgeBio heart drug approved by FDA, setting up battle with Pfizer

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study

Zacks

3 months ago

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study

Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment

Clinical Trials Arena

3 months ago

Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment

MT Newswires

3 months ago

Alnylam Pharmaceuticals Says Nucresiran Performed Well in Phase 1 Transthyretin Amyloidosis Study

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

Business Wire

3 months ago

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

Morningstar Research

3 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

MT Newswires

3 months ago

Alnylam Pharmaceuticals Shares Fall After Wolfe Downgrade

MT Newswires

3 months ago

Wolfe Downgrades Alnylam Pharmaceuticals to Underperform From Peer Perform, Price Target at $205

3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%

Simply Wall St.

3 months ago

3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

Pharmaceutical Technology

4 months ago

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

An RNAi renaissance is creating a new generation of startups

BioPharma Dive

4 months ago

An RNAi renaissance is creating a new generation of startups

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

Business Wire

4 months ago

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down

Zacks

4 months ago

Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down

Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

4 months ago

Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight

GuruFocus.com

4 months ago

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight

Thomson Reuters StreetEvents

4 months ago

Q3 2024 Alnylam Pharmaceuticals Inc Earnings Call

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks

4 months ago

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say

Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates

Zacks

4 months ago

Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates

MT Newswires

4 months ago

Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Net Loss, Revenue Falls

Associated Press Finance

4 months ago

Alnylam: Q3 Earnings Snapshot

Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Business Wire

4 months ago

Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Cognizant signs deal to enhance Alnylam’s IT infrastructure

Verdict

4 months ago

Cognizant signs deal to enhance Alnylam’s IT infrastructure

Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024

Business Wire

4 months ago

Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024

MT Newswires

4 months ago

Cognizant Selected as Alnylam's IT Services Provider

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth

Zacks

4 months ago

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

4 months ago

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

4 months ago

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?

Zacks

4 months ago

Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?

NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B

Zacks

4 months ago

NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

Zacks

4 months ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

High Growth Tech Stocks to Watch in October 2024

Simply Wall St.

4 months ago

High Growth Tech Stocks to Watch in October 2024

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU

Zacks

4 months ago

Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

Business Wire

4 months ago

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

MT Newswires

4 months ago

Alnylam Submits Regulatory Application to EMA for ATTR Amyloidosis With Cardiomyopathy Treatment

MT Newswires

4 months ago

Scotiabank Initiates Alnylam Pharmaceuticals at Sector Outperform With $305 Price Target

Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Business Wire

4 months ago

Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

Zacks

4 months ago

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

Share on Social Networks: